SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceuticals board to consider interim dividend

13 Dec 2016 Evaluate

Kwality Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on December 22, 2016, to consider the interim dividend for the financial year 2016-17. Further in accordance with the Company’s code of conduct for prevention of insider trading, the trading window will be closed with effect from December 13, 2016 till 48 hours from the conclusion of the meeting.

The above information is a part of company’s filings submitted to BSE.

Kwality Pharma Share Price

1583.75 -80.55 (-4.84%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×